Marvin Edeas - LinkedIn
Marvin Edeas’ Background
With the SOD (Superoxide Dismutase Enzymes) lying at the heart of his work, Marvin edeas, together with Joe McCord, organised the very first world congress on this issue at the Pasteur Institute. In 1998, he obtained his doctorate from Antoine Béclère Hospital on HIV infections in asymptomatic patients. He focused on gastrointestinal disease in Pitié Salpêtrière’s Internal Medicine Department. Marvin Edeas followed a course at Paris Descartes University on infectious diseases.
In the 1990s, Marvin Edeas conducted significant research on the acquired immunodeficiency virus. In 1997, he defined the factors that produce blastogenic plasma in Type 1 cases of HIV. The latency mechanisms of HIV in patients who are HIV-positive, on top of the activation factors, is a field which he gave six years to studying at Antoine Béclère Hospital. Sidaction rewarded Marvin Edeas for his work on HIV.
Ever since the year 2016, Marvin Edeas has worked with the Paris Descartes University (Cochin Institute) as a professor (visiting). Marvin Edeas joined up with a team responsible for inflammation, oxidative stress and cell proliferation. The effects of Oxidative Stress and Inflammation in chronic diseases is a topic his research focuses on.
Marvin Edeas - Chair of the French Society (SFA) and International Society of Antioxidants (ISANH) and Founder of the World Mitochondria Society (WMS)
Scientific studies on inflammation and microbiota, cell signalling, the activation of Nrf2 transcription factors and their significance in various pathologies are at the heart of Marvin Edeas’ work. Most notably, he investigates the relationship between mitochondria and microbiota. Through the SFA, Marvin Edeas encourages collaboration and exchanges between biologists, researchers, industrialists and doctors, etc. Coupled with being committed to their applications in preventative and therapeutic treatments, the SFA promotes the usage of antioxidants in health and nutrition.